- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 23.04. | Shuttle Pharmaceuticals Holdings, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 23.04. | Shuttle Pharmaceuticals Holdings, Inc.: Shuttle Pharmaceuticals to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024 & 1x1 Meetings on Thursday, May 2, 2024 | 1 | GlobeNewswire (USA) | ||
| 05.04. | Shuttle Pharmaceuticals files to sell subscription rights to buy $4.5M in units | 1 | Seeking Alpha | ||
| 05.04. | Shuttle Pharmaceuticals Holdings, Inc. - S-1, General form for registration of securities | 1 | SEC Filings | ||
| 03.04. | Shuttle Pharmaceuticals Holdings, Inc.: Shuttle Pharmaceuticals to Present at the Emerging Growth Conference on April 4, 2024 | 1 | GlobeNewswire (USA) | ||
| 22.03. | Shuttle Pharmaceuticals Holdings, Inc.: Shuttle Pharma Provides Fourth Quarter 2023 Corporate Update | 78 | PR Newswire | GAITHERSBURG, Md., March 22, 2024 /PRNewswire/ -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) ("Shuttle Pharma"), a discovery and development stage specialty pharmaceutical company focused... ► Artikel lesen | |
| 22.03. | Shuttle Pharma advances cancer treatment with FDA trial nod | 1 | Investing.com | ||
| 22.03. | Shuttle Pharmaceuticals Holdings, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 21.03. | Shuttle Pharmaceuticals Holdings, Inc. - 10-K, Annual Report | 1 | SEC Filings | ||
| 05.03. | Shuttle Pharmaceuticals Holdings, Inc.: Shuttle Pharmaceuticals to Present at the Emerging Growth Conference on March 6, 2024 | 1 | GlobeNewswire (USA) | ||
| 05.03. | Shuttle Pharmaceuticals Holdings, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 13.02. | Shuttle Pharmaceuticals to launch $4.5 million rights offering | 1 | Investing.com | ||
| 13.02. | Shuttle Pharmaceuticals Holdings, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 05.02. | Shuttle Pharmaceuticals Holdings, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 08.01. | Shuttle Pharmaceuticals Holdings, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 08.01. | Shuttle Pharmaceuticals Holdings, Inc.: Shuttle Pharmaceuticals Receives FDA Approval to Proceed with Phase II Clinical Trial of Ropidoxuridine for Treatment of Patients with Glioblastoma | 124 | PR Newswire | ROCKVILLE, Md., Jan. 8, 2024 /PRNewswire/ -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) ("Shuttle Pharma") today announced they have received the 'Safe to Proceed' letter from the U.S.... ► Artikel lesen | |
| 19.12.23 | Shuttle Pharmaceuticals Holdings, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 11.12.23 | Shuttle Pharmaceuticals Holdings, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 30.11.23 | Shuttle Pharmaceuticals Holdings, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 14.11.23 | Shuttle Pharmaceuticals reports Q3 results | 1 | Seeking Alpha |
Seite:
1 2 Weiter >>
21 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ASTRIA THERAPEUTICS | 9,500 | +4,97 % | Astria Therapeutics Reports First Quarter 2024 Financial Results and Provides a Corporate Update | BOSTON--(BUSINESS WIRE)--Astria Therapeutics, Inc. (NASDAQ:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunological diseases, today reported... ► Artikel lesen | |
| ROCKET LAB USA | 3,705 | -2,76 % | EQS-News: Mynaric AG: Mynaric wurde von Rocket Lab für das Tranche 2 Transport Layer - Beta Programm der Space Development Agency ausgewählt | EQS-News: Mynaric AG
/ Schlagwort(e): Auftragseingänge
Mynaric wurde von Rocket Lab für das Tranche 2 Transport Layer - Beta Programm der Space Development Agency ausgewählt
07.05.2024... ► Artikel lesen | |
| BOIRON | 33,600 | 0,00 % | BOIRON: Outlook 2023 - Communication calendar 2024 | The Board of Directors of Laboratoires BOIRON met on 19 December 2023, under the chairmanship of Mr Thierry Boiron.
At this meeting, the Board reviewed the latest business and earnings forecasts... ► Artikel lesen | |
| MEDICINOVA | 1,300 | +8,33 % | MediciNova, Inc.: MediciNova Receives Issue Notification for New Patent Covering Extended-Release Formulations of MN-166 (ibudilast) | LA JOLLA, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the Tokyo Stock Exchange... ► Artikel lesen | |
| ESSA PHARMA | 6,240 | -0,16 % | Essa Pharma Inc. Reports Results Of Annual General Meeting Of Shareholders | SOUTH SAN FRANCISCO, USA and VANCOUVER, CANADA, March 7, 2024 /PRNewswire/ - ESSA Pharma Inc. ("ESSA" or the "Company") (NASDAQ: EPIX), a clinical stage pharmaceutical company focused on developing... ► Artikel lesen | |
| AQUESTIVE THERAPEUTICS | 3,090 | -6,08 % | Aquestive Therapeutics, Inc.: Aquestive Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update | Met all endpoints in Phase 3 pivotal study for Anaphylm (epinephrine) Sublingual Film in first quarter 2024 when compared to EpiPen® and other injectors used for the treatment of anaphylaxisOn track... ► Artikel lesen | |
| HARROW | 11,600 | +12,73 % | Harrow Health, Inc. Announces Fourth Quarter and Year-End 2023 Financial Results | NASHVILLE, Tenn.--(BUSINESS WIRE)--Harrow (Nasdaq: HROW), a leading U.S. eyecare pharmaceutical company, announced results for the fourth quarter and year ended December 31, 2023. The Company also... ► Artikel lesen | |
| SHINECO | 0,772 | +2,24 % | Shineco, Inc.: Shineco Regains Compliance with Nasdaq Minimum Bid Price Requirement | BEIJING, March 12, 2024 (GLOBE NEWSWIRE) -- Shineco, Inc. ("Shineco" or the "Company"; NASDAQ: SISI), a provider of technologically advanced healthcare products and services, announced today that... ► Artikel lesen | |
| CUMBERLAND PHARMACEUTICALS | 1,680 | -2,89 % | Cumberland Pharmaceuticals Inc.: Cumberland Pharmaceuticals Reports First Quarter 2024 Financial Results & Company Update | NASHVILLE, TENN., May 7, 2024 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company, today announced that its product portfolio of FDA-approved brands... ► Artikel lesen | |
| CYANOTECH | 0,260 | 0,00 % | Delisting of Securities of NanoString Technologies, Inc.; Remark Holdings, Inc.; Sunworks, Inc.; Cyanotech Corporation; Sientra, Inc.; Charge Enterprises, Inc. and others from The Nasdaq Stock Market | NEW YORK, April 08, 2024 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the common stock of NanoString Technologies, Inc. NanoString Technologies, Inc.'s securities... ► Artikel lesen | |
| REVIVA PHARMACEUTICALS | 1,870 | -12,62 % | Reviva Pharmaceuticals: Reviva Announces FDA Alignment on Brilaroxazine Clinical Trials for NDA in Schizophrenia | - FDA acceptance of 4-week global registrational Phase 3 RECOVER-2 study - - Two positive 4-week studies plus a 12-month long-term safety study have potential to support a New Drug Application (NDA)... ► Artikel lesen | |
| LYRA THERAPEUTICS | 0,373 | -3,62 % | Lyra Therapeutics Reports Topline Results from Phase 3 ENLIGHTEN 1 Trial for LYR-210 in Chronic Rhinosinusitis | ENLIGHTEN 1 trial did not meet its primary endpoint Company plans to evaluate full dataset and path forward WATERTOWN, Mass., May 06, 2024 (GLOBE NEWSWIRE) -- Lyra Therapeutics, Inc. (Nasdaq: LYRA)... ► Artikel lesen | |
| BAYER | 28,955 | +0,92 % | Bayer, RWE, Infineon, Zalando: DAX-Überblick | Nach der Feiertagspause am Mittwoch hat der DAX (WKN: 846900) am Donnerstag etwas nachgegeben. In einem trägen Handel büßte das größte deutsche Börsenbarometer 35 Punkte ein und beendete den Handel... ► Artikel lesen | |
| MERCK KGAA | 155,50 | -0,13 % | JPMORGAN stuft MERCK KGAA auf 'Overweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Aktien der Merck KGaA auf "Overweight" mit einem Kursziel von 190 Euro belassen. Die Mitte Mai anstehenden Zahlen dürften ein vergleichsweise... ► Artikel lesen | |
| NOVO NORDISK | 119,76 | +0,91 % | Märkte am Morgen: Baidu, Nio, Apple, Moderna, Daimler Truck, Novo Nordisk, PBB, LVMH, ASML, Nordex | Der DAX hat sich gestern nach dem Feiertag wenig bewegt präsentiert. Letzen Endes schloss der DAX 0,2 Prozent tiefer bei 17.896 Punkten. Heute könnte es bereits wieder nach oben gehen. Die Vorgaben... ► Artikel lesen |
SHUTTLE PHARMACEUTICALS HOLDINGS INC gehört der Branche Pharma an. Mit einer aktuellen Kursveränderung von +0,019 (+4,73 %) liegt der Kurs bei 0,410 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
